Advertisement

If you have an ACS member number, please enter it here so we can link this account to your membership. (optional)

ACS values your privacy. By submitting your information, you are gaining access to C&EN and subscribing to our weekly newsletter. We use the information you provide to make your reading experience better, and we will never sell your data to third party members.

ENJOY UNLIMITED ACCES TO C&EN

Business

Technology Incubator Launches Biopolymer Venture

October 22, 2007 | A version of this story appeared in Volume 85, Issue 43

Emergence, a Berkeley, Calif.-based life sciences technology development firm, and ExThera, a technology transfer partner of the Karolinska Institute in Stockholm, have formed a joint venture, ExThera Medical, to develop and market polymers for medical devices based on biologically active carbohydrates that remove pathogenic microorganisms, proteins, and cells from blood. The first clinical application for the technology will be in the treatment of sepsis in intensive care units. Emergence is a spin-off of Polymer Technology Group, which will provide R&D and manufacturing to ExThera Medical.

Article:

This article has been sent to the following recipient:

0 /1 FREE ARTICLES LEFT THIS MONTH Remaining
Chemistry matters. Join us to get the news you need.